Dong Wha Pharm signs exclusive sales agreement of FDA-approved adhesive barrier with Genzyme Korea
Dong Wha Pharm(Chairman Doh-Joon Yoon) signed an exclusive distribution and sales agreement of the deep-cavity wound dressing Seprafilm(adhesion barrier) to Korea with the Sanofi Group’s corporate body of specialty care, Genzyme Korea(CEO Hee-Kyung Park).
Under the agreement, Dong Wha Pharm will...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
